Therapeutics: Solute carrier family 22 organic cation transporter member 2 (SLC22A2; OCT2); POU class 2 associating factor 1 (POU2AF1; BOB1)

Patient sample and cell culture studies suggest inhibiting SLC22A2 or POU2AF1 could help treat diffuse large B cell lymphoma (DLBCL). Genetic sequencing of tumor samples from 207 DLBCL patients identi...